Search results
Mussel-inspired nanoparticle assembly tech to aid energy applications
Interesting Engineering· 6 days agoThis technique will control functional nanoparticle assembly into uniform monolayers over large...
An Innovative New Cancer Treatment – Scientists Unveil Nanoparticle Capable of Crossing Blood-Brain...
SciTechDaily· 3 days agoResearchers from the Sylvester Comprehensive Cancer Center at the University of Miami Miller School...
Nanoparticle plant virus treatment shows promise in fighting metastatic cancers in mice
Phys.org· 1 day agoThe treatment, composed of nanoparticles fashioned from the cowpea mosaic virus—a virus that infects black-eyed pea plants—showed remarkable success in improving survival ...
Formosa and Tabuk sign deal for FDA-approved ophthalmic suspension
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe agreement includes upfront payments and milestone payments on meeting commercialisation and...
Researchers create nanoparticle that crosses blood-brain barrier
Becker’s Hospital Review· 7 days agoResearchers at the Sylvester Comprehensive Cancer Center at the University of Miami have developed a nanoparticle that can cross the blood-brain barrier, potentially opening ...
Overcoming thermostability challenges in mRNA–lipid nanoparticle systems with piperidine-based...
Nature· 5 days agoPiperidine-based ionizable lipids avoid the formation of mRNA–lipid adduct that is responsible for the loss-of-function of mRNA and contribute to the long-term storage stability of mRNA/LNPs as a wet preparation.
Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for...
FOX 4 Kansas City· 6 days agoTaiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
CBS 47 Fresno· 5 days agoNovavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi (Nasdaq: SNY). The ...
SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Cancer
Fort Wayne Journal Gazette· 5 days agoSN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track...
Just Say No to Drugs: 3 Pharma Stocks to Avoid
InvestorPlace via Yahoo Finance· 6 days agoFrom its stellar performance in 2021 to deflating in 2022, the biotech sector continued its stagnation into 2023, highlighting some pharma stocks to...